#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat|salience|identity|centering
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent
#Summary1=(human1) A physician report on examining a 41-year-old white male with HIV disease (stable control on Atripla), resolving left gluteal abscess, diabetes on oral therapy, hypertension, depression and chronic pain, and plans to continue medication (Gabapentin, Metformin, Glipizide, Atripla etc.) and psychological treatment, order lab work in 3-4 weeks and then see him a few weeks later.
#Summary2=(claude-3-5-sonnet-20241022; postedited) A 41-year-old male with controlled HIV, hypertension, newly diagnosed diabetes on oral therapy, and depression presents with improving left gluteal abscess post-I&D, showing CD4 count of 425 and viral load <50, but with blood pressure (145/90) and pulse (123).
#Summary3=(gpt4o) A 41-year-old male with stable HIV on Atripla, resolving left gluteal abscess on Flagyl, newly diagnosed diabetes on oral therapy, hypertension, depression, and unclear musculoskeletal pain is feeling better, advised to continue current medications, and follow up with labs in 3-4 weeks and his psychologist, with a physical exam showing minimal abnormalities.
#Summary4=(Meta-Llama-3-8B-Instruct) A 41-year-old man with HIV disease and stable control on Atripla is being managed for a resolving left gluteal abscess, newly diagnosed diabetes, hypertension, depression, and chronic musculoskeletal pain.
#Summary5=(Qwen2.5-3B-Instruct; postedited) A 41-year-old HIV patient with stable viral load, diabetes mellitus on oral therapy, hypertension, and depression reports resolving abscess, will see a psychologist and will have laboratory studies in 3-4 weeks.


#Text=Description :
1-1	0-11	Description	abstract[1]	new[1]	nnnnn[1]	_	cf1[1]	_	_	
1-2	12-13	:	_	_	_	_	_	_	_	

#Text=Human immunodeficiency virus disease with stable control on Atripla .
2-1	14-19	Human	abstract[3]|animal[4]	new[3]|new[4]	sssss[3]|nssss[4]	HIV[4]	cf2[3]|cf3[4]	coref|coref	6-3[19_3]|7-16[24_4]	
2-2	20-36	immunodeficiency	abstract[3]|animal[4]	new[3]|new[4]	sssss[3]|nssss[4]	HIV[4]	cf2[3]|cf3[4]	_	_	
2-3	37-42	virus	abstract[3]|animal[4]	new[3]|new[4]	sssss[3]|nssss[4]	HIV[4]	cf2[3]|cf3[4]	_	_	
2-4	43-50	disease	abstract[3]	new[3]	sssss[3]	_	cf2[3]	_	_	
2-5	51-55	with	abstract[3]	new[3]	sssss[3]	_	cf2[3]	_	_	
2-6	56-62	stable	abstract[3]	new[3]	sssss[3]	_	cf2[3]	_	_	
2-7	63-70	control	abstract[3]	new[3]	sssss[3]	_	cf2[3]	_	_	
2-8	71-73	on	abstract[3]	new[3]	sssss[3]	_	cf2[3]	_	_	
2-9	74-81	Atripla	abstract[3]|substance[5]	new[3]|new[5]	sssss[3]|snssn[5]	Efavirenz/emtricitabine/tenofovir[5]	cf2[3]|cf1[5]	coref	24-2[124_5]	
2-10	82-83	.	_	_	_	_	_	_	_	

#Text=Resolving left gluteal abscess , completing Flagyl .
3-1	84-93	Resolving	_	_	_	_	_	_	_	
3-2	94-98	left	object[7]	new[7]	sssss[7]	_	cf2[7]	coref	9-6[39_7]	
3-3	99-106	gluteal	object[7]	new[7]	sssss[7]	_	cf2[7]	_	_	
3-4	107-114	abscess	object[7]	new[7]	sssss[7]	_	cf2[7]	_	_	
3-5	115-116	,	_	_	_	_	_	_	_	
3-6	117-127	completing	_	_	_	_	_	_	_	
3-7	128-134	Flagyl	substance[8]	new[8]	nnsnn[8]	Metronidazole[8]	cf1[8]	coref	21-2[112_8]	
3-8	135-136	.	_	_	_	_	_	_	_	

#Text=Diabetes mellitus , currently on oral therapy .
4-1	137-145	Diabetes	abstract[10]	new[10]	sssss[10]	Diabetes[10]	cf1[10]	coref	9-22[45_10]	
4-2	146-154	mellitus	abstract[10]	new[10]	sssss[10]	Diabetes[10]	cf1[10]	_	_	
4-3	155-156	,	_	_	_	_	_	_	_	
4-4	157-166	currently	_	_	_	_	_	_	_	
4-5	167-169	on	_	_	_	_	_	_	_	
4-6	170-174	oral	abstract[11]	new[11]	sssns[11]	_	cf2[11]	coref	42-7[220_11]	
4-7	175-182	therapy	abstract[11]	new[11]	sssns[11]	_	cf2[11]	_	_	
4-8	183-184	.	_	_	_	_	_	_	_	

#Text=Hypertension , depression , and chronic musculoskeletal pain of unclear etiology .
5-1	185-197	Hypertension	abstract[12]	new[12]	sssss[12]	_	cf1[12]	coref	10-7[49_12]	
5-2	198-199	,	_	_	_	_	_	_	_	
5-3	200-210	depression	abstract[13]	new[13]	sssss[13]	_	cf2[13]	coref	44-2[222_13]	
5-4	211-212	,	_	_	_	_	_	_	_	
5-5	213-216	and	_	_	_	_	_	_	_	
5-6	217-224	chronic	abstract[16]	new[16]	snssn[16]	_	cf3[16]	coref	45-2[225_16]	
5-7	225-240	musculoskeletal	abstract[16]	new[16]	snssn[16]	_	cf3[16]	_	_	
5-8	241-245	pain	abstract[16]	new[16]	snssn[16]	_	cf3[16]	_	_	
5-9	246-248	of	abstract[16]	new[16]	snssn[16]	_	cf3[16]	_	_	
5-10	249-256	unclear	abstract[16]|abstract[17]	new[16]|new[17]	snssn[16]|nnnnn[17]	_	cf3[16]|cf4[17]	coref	45-6[226_17]	
5-11	257-265	etiology	abstract[16]|abstract[17]	new[16]|new[17]	snssn[16]|nnnnn[17]	_	cf3[16]|cf4[17]	_	_	
5-12	266-267	.	_	_	_	_	_	_	_	

#Text=HISTORY OF PRESENT ILLNESS :
6-1	268-275	HISTORY	abstract[18]	new[18]	nnnnn[18]	_	cf2[18]	coref	7-13[22_18]	
6-2	276-278	OF	abstract[18]	new[18]	nnnnn[18]	_	cf2[18]	_	_	
6-3	279-286	PRESENT	abstract[18]|abstract[19]	new[18]|giv:inact[19]	nnnnn[18]|sssss[19]	_	cf2[18]|cf1[19]	coref	7-16[23_19]	
6-4	287-294	ILLNESS	abstract[18]|abstract[19]	new[18]|giv:inact[19]	nnnnn[18]|sssss[19]	_	cf2[18]|cf1[19]	_	_	
6-5	295-296	:	_	_	_	_	_	_	_	

#Text=The patient is a 41 - year - old white male with a history of HIV disease .
7-1	297-300	The	person[20]	new[20]	ssssn[20]	_	cf1[20]	pred	7-4[21_20]	
7-2	301-308	patient	person[20]	new[20]	ssssn[20]	_	cf1[20]	_	_	
7-3	309-311	is	_	_	_	_	_	_	_	
7-4	312-313	a	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	ana	8-1[27_21]	
7-5	314-316	41	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-6	317-318	-	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-7	319-323	year	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-8	324-325	-	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-9	326-329	old	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-10	330-335	white	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-11	336-340	male	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-12	341-345	with	person[21]	giv:act[21]	ssssn[21]	_	cf1[21]	_	_	
7-13	346-347	a	person[21]|abstract[22]	giv:act[21]|giv:act[22]	ssssn[21]|nnnnn[22]	_	cf1[21]|cf2*[22]	_	_	
7-14	348-355	history	person[21]|abstract[22]	giv:act[21]|giv:act[22]	ssssn[21]|nnnnn[22]	_	cf1[21]|cf2*[22]	_	_	
7-15	356-358	of	person[21]|abstract[22]	giv:act[21]|giv:act[22]	ssssn[21]|nnnnn[22]	_	cf1[21]|cf2*[22]	_	_	
7-16	359-362	HIV	person[21]|abstract[22]|abstract[23]|animal[24]	giv:act[21]|giv:act[22]|giv:act[23]|giv:inact[24]	ssssn[21]|nnnnn[22]|sssss[23]|nssss[24]	HIV[24]	cf1[21]|cf2*[22]|cf3[23]|cf4[24]	coref|coref	40-2[212_23]|40-2[213_24]	
7-17	363-370	disease	person[21]|abstract[22]|abstract[23]	giv:act[21]|giv:act[22]|giv:act[23]	ssssn[21]|nnnnn[22]|sssss[23]	_	cf1[21]|cf2*[22]|cf3[23]	_	_	
7-18	371-372	.	_	_	_	_	_	_	_	

#Text=His last CD4 count was 425 , viral load was less than 50 in 08 / 07 .
8-1	373-376	His	abstract[26]|person[27]	new[26]|giv:act[27]	nsnnn[26]|ssssn[27]	_	cf2[26]|cf1*[27]	coref|ana	8-6[29_26]|9-1[37_27]	
8-2	377-381	last	abstract[26]	new[26]	nsnnn[26]	_	cf2[26]	_	_	
8-3	382-385	CD4	abstract[26]|animal[28]	new[26]|new[28]	nsnnn[26]|nsnnn[28]	CD4[28]	cf2[26]|cf6[28]	_	_	
8-4	386-391	count	abstract[26]	new[26]	nsnnn[26]	_	cf2[26]	_	_	
8-5	392-395	was	_	_	_	_	_	_	_	
8-6	396-399	425	abstract[29]	giv:act[29]	nsnnn[29]	_	cf2[29]	_	_	
8-7	400-401	,	_	_	_	_	_	_	_	
8-8	402-407	viral	abstract[33]	new[33]	nsnnn[33]	_	cf3[33]	_	_	
8-9	408-412	load	abstract[33]	new[33]	nsnnn[33]	_	cf3[33]	_	_	
8-10	413-416	was	_	_	_	_	_	_	_	
8-11	417-421	less	_	_	_	_	_	_	_	
8-12	422-426	than	_	_	_	_	_	_	_	
8-13	427-429	50	abstract[34]	new[34]	nsnnn[34]	_	cf4[34]	_	_	
8-14	430-432	in	_	_	_	_	_	_	_	
8-15	433-435	08	time[36]	new[36]	nnnnn[36]	_	cf5[36]	_	_	
8-16	436-437	/	time[36]	new[36]	nnnnn[36]	_	cf5[36]	_	_	
8-17	438-440	07	time[36]	new[36]	nnnnn[36]	_	cf5[36]	_	_	
8-18	441-442	.	_	_	_	_	_	_	_	

#Text=He was recently hospitalized for left gluteal abscess , for which he underwent I & D and he has newly diagnosed diabetes mellitus .
9-1	443-445	He	person[37]	giv:act[37]	ssssn[37]	_	cf1*[37]	ana	9-12[40_37]	
9-2	446-449	was	_	_	_	_	_	_	_	
9-3	450-458	recently	_	_	_	_	_	_	_	
9-4	459-471	hospitalized	_	_	_	_	_	_	_	
9-5	472-475	for	_	_	_	_	_	_	_	
9-6	476-480	left	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	coref	12-22[68_39]	
9-7	481-488	gluteal	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-8	489-496	abscess	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-9	497-498	,	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-10	499-502	for	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-11	503-508	which	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-12	509-511	he	object[39]|person[40]	giv:inact[39]|giv:act[40]	sssss[39]|ssssn[40]	_	cf3[39]|cf1*[40]	ana	9-18[43_40]	
9-13	512-521	underwent	object[39]	giv:inact[39]	sssss[39]	_	cf3[39]	_	_	
9-14	522-523	I	object[39]|event[42]	giv:inact[39]|new[42]	sssss[39]|nsnnn[42]	_	cf3[39]|cf4[42]	_	_	
9-15	524-525	&	object[39]|event[42]	giv:inact[39]|new[42]	sssss[39]|nsnnn[42]	_	cf3[39]|cf4[42]	_	_	
9-16	526-527	D	object[39]|event[42]	giv:inact[39]|new[42]	sssss[39]|nsnnn[42]	_	cf3[39]|cf4[42]	_	_	
9-17	528-531	and	_	_	_	_	_	_	_	
9-18	532-534	he	person[43]	giv:act[43]	ssssn[43]	_	cf1*[43]	ana	10-1[46_43]	
9-19	535-538	has	_	_	_	_	_	_	_	
9-20	539-544	newly	_	_	_	_	_	_	_	
9-21	545-554	diagnosed	_	_	_	_	_	_	_	
9-22	555-563	diabetes	abstract[45]	giv:inact[45]	sssss[45]	Diabetes[45]	cf2[45]	coref	42-2[219_45]	
9-23	564-572	mellitus	abstract[45]	giv:inact[45]	sssss[45]	Diabetes[45]	cf2[45]	_	_	
9-24	573-574	.	_	_	_	_	_	_	_	

#Text=He also has a history of hypertension and hypertriglyceridemia .
10-1	575-577	He	person[46]	giv:act[46]	ssssn[46]	_	cf1*[46]	ana	11-1[51_46]	
10-2	578-582	also	_	_	_	_	_	_	_	
10-3	583-586	has	_	_	_	_	_	_	_	
10-4	587-588	a	abstract[48]	new[48]	nnnnn[48]	_	cf3[48]	_	_	
10-5	589-596	history	abstract[48]	new[48]	nnnnn[48]	_	cf3[48]	_	_	
10-6	597-599	of	abstract[48]	new[48]	nnnnn[48]	_	cf3[48]	_	_	
10-7	600-612	hypertension	abstract[48]|abstract[49]	new[48]|giv:inact[49]	nnnnn[48]|sssss[49]	_	cf3[48]|cf2[49]	coref	43-2[221_49]	
10-8	613-616	and	abstract[48]	new[48]	nnnnn[48]	_	cf3[48]	_	_	
10-9	617-637	hypertriglyceridemia	abstract[48]|abstract[50]	new[48]|new[50]	nnnnn[48]|nnnnn[50]	_	cf3[48]|cf4[50]	_	_	
10-10	638-639	.	_	_	_	_	_	_	_	

#Text=He had been having increased urination and thirst .
11-1	640-642	He	person[51]	giv:act[51]	ssssn[51]	_	cf1*[51]	ana	12-1[54_51]	
11-2	643-646	had	_	_	_	_	_	_	_	
11-3	647-651	been	_	_	_	_	_	_	_	
11-4	652-658	having	_	_	_	_	_	_	_	
11-5	659-668	increased	_	_	_	_	_	_	_	
11-6	669-678	urination	event[52]	new[52]	nnnnn[52]	_	cf2[52]	_	_	
11-7	679-682	and	_	_	_	_	_	_	_	
11-8	683-689	thirst	abstract[53]	new[53]	nnnnn[53]	_	cf3[53]	_	_	
11-9	690-691	.	_	_	_	_	_	_	_	

#Text=He was seen in the hospital by the endocrinology staff and treated with insulin while hospitalized and getting treatment for his perirectal abscess .
12-1	692-694	He	person[54]	giv:act[54]	ssssn[54]	_	cf1*[54]	ana	12-21[66_54]	
12-2	695-698	was	_	_	_	_	_	_	_	
12-3	699-703	seen	_	_	_	_	_	_	_	
12-4	704-706	in	_	_	_	_	_	_	_	
12-5	707-710	the	place[61]	acc:com[61]	nnnnn[61]	_	cf4[61]	bridge:def	12-8[62_61]	
12-6	711-719	hospital	place[61]	acc:com[61]	nnnnn[61]	_	cf4[61]	_	_	
12-7	720-722	by	_	_	_	_	_	_	_	
12-8	723-726	the	person[62]	acc:inf[62]	nnnnn[62]	_	cf3[62]	_	_	
12-9	727-740	endocrinology	person[62]	acc:inf[62]	nnnnn[62]	_	cf3[62]	_	_	
12-10	741-746	staff	person[62]	acc:inf[62]	nnnnn[62]	_	cf3[62]	_	_	
12-11	747-750	and	_	_	_	_	_	_	_	
12-12	751-758	treated	_	_	_	_	_	_	_	
12-13	759-763	with	_	_	_	_	_	_	_	
12-14	764-771	insulin	substance[63]	new[63]	nnnnn[63]	_	cf6[63]	coref	13-7[70_63]	
12-15	772-777	while	_	_	_	_	_	_	_	
12-16	778-790	hospitalized	_	_	_	_	_	_	_	
12-17	791-794	and	_	_	_	_	_	_	_	
12-18	795-802	getting	_	_	_	_	_	_	_	
12-19	803-812	treatment	abstract[65]	new[65]	nnnnn[65]	_	cf5[65]	_	_	
12-20	813-816	for	abstract[65]	new[65]	nnnnn[65]	_	cf5[65]	_	_	
12-21	817-820	his	abstract[65]|person[66]	new[65]|giv:act[66]	nnnnn[65]|ssssn[66]	_	cf5[65]|cf1*[66]	coref	13-12[72_66]	
12-22	821-831	perirectal	abstract[65]|object[68]	new[65]|giv:inact[68]	nnnnn[65]|sssss[68]	_	cf5[65]|cf2[68]	coref	16-4[89_68]	
12-23	832-839	abscess	abstract[65]|object[68]	new[65]|giv:inact[68]	nnnnn[65]|sssss[68]	_	cf5[65]|cf2[68]	_	_	
12-24	840-841	.	_	_	_	_	_	_	_	

#Text=The endocrine team apparently felt that insulin might be best for this patient , but because of financial issues , elected to place him on Glucophage and glyburide .
13-1	842-845	The	organization[69]	new[69]	nnnnn[69]	_	cf3[69]	_	_	
13-2	846-855	endocrine	organization[69]	new[69]	nnnnn[69]	_	cf3[69]	_	_	
13-3	856-860	team	organization[69]	new[69]	nnnnn[69]	_	cf3[69]	_	_	
13-4	861-871	apparently	_	_	_	_	_	_	_	
13-5	872-876	felt	_	_	_	_	_	_	_	
13-6	877-881	that	_	_	_	_	_	_	_	
13-7	882-889	insulin	substance[70]	giv:act[70]	nnnnn[70]	_	cf2[70]	_	_	
13-8	890-895	might	_	_	_	_	_	_	_	
13-9	896-898	be	_	_	_	_	_	_	_	
13-10	899-903	best	_	_	_	_	_	_	_	
13-11	904-907	for	_	_	_	_	_	_	_	
13-12	908-912	this	person[72]	giv:act[72]	ssssn[72]	_	cf1*[72]	ana	13-24[74_72]	
13-13	913-920	patient	person[72]	giv:act[72]	ssssn[72]	_	cf1*[72]	_	_	
13-14	921-922	,	_	_	_	_	_	_	_	
13-15	923-926	but	_	_	_	_	_	_	_	
13-16	927-934	because	_	_	_	_	_	_	_	
13-17	935-937	of	_	_	_	_	_	_	_	
13-18	938-947	financial	abstract[73]	new[73]	nnnnn[73]	_	cf6[73]	_	_	
13-19	948-954	issues	abstract[73]	new[73]	nnnnn[73]	_	cf6[73]	_	_	
13-20	955-956	,	_	_	_	_	_	_	_	
13-21	957-964	elected	_	_	_	_	_	_	_	
13-22	965-967	to	_	_	_	_	_	_	_	
13-23	968-973	place	_	_	_	_	_	_	_	
13-24	974-977	him	person[74]	giv:act[74]	ssssn[74]	_	cf1*[74]	coref	14-1[81_74]	
13-25	978-980	on	_	_	_	_	_	_	_	
13-26	981-991	Glucophage	substance[76]|substance[77]	new[76]|new[77]	nnnnn[76]|nnnnn[77]	Metformin[77]	cf4[76]|cf5[77]	coref	14-9[84_76]	
13-27	992-995	and	substance[76]	new[76]	nnnnn[76]	_	cf4[76]	_	_	
13-28	996-1005	glyburide	substance[76]|substance[78]	new[76]|new[78]	nnnnn[76]|nnnnn[78]	Glibenclamide[78]	cf4[76]|cf7[78]	_	_	
13-29	1006-1007	.	_	_	_	_	_	_	_	

#Text=The patient reports that he has been taking the medication .
14-1	1008-1011	The	person[81]	giv:act[81]	ssssn[81]	_	cf1*[81]	ana	14-5[82_81]	
14-2	1012-1019	patient	person[81]	giv:act[81]	ssssn[81]	_	cf1*[81]	_	_	
14-3	1020-1027	reports	_	_	_	_	_	_	_	
14-4	1028-1032	that	_	_	_	_	_	_	_	
14-5	1033-1035	he	person[82]	giv:act[82]	ssssn[82]	_	cf1*[82]	ana	15-1[85_82]	
14-6	1036-1039	has	_	_	_	_	_	_	_	
14-7	1040-1044	been	_	_	_	_	_	_	_	
14-8	1045-1051	taking	_	_	_	_	_	_	_	
14-9	1052-1055	the	substance[84]	giv:act[84]	nnnnn[84]	_	cf2[84]	_	_	
14-10	1056-1066	medication	substance[84]	giv:act[84]	nnnnn[84]	_	cf2[84]	_	_	
14-11	1067-1068	.	_	_	_	_	_	_	_	

#Text=He is in general feeling better .
15-1	1069-1071	He	person[85]	giv:act[85]	ssssn[85]	_	cf1*[85]	ana	16-1[86_85]	
15-2	1072-1074	is	_	_	_	_	_	_	_	
15-3	1075-1077	in	_	_	_	_	_	_	_	
15-4	1078-1085	general	_	_	_	_	_	_	_	
15-5	1086-1093	feeling	_	_	_	_	_	_	_	
15-6	1094-1100	better	_	_	_	_	_	_	_	
15-7	1101-1102	.	_	_	_	_	_	_	_	

#Text=He says that his gluteal abscess is improving and he will be following up with Surgery today .
16-1	1103-1105	He	person[86]	giv:act[86]	ssssn[86]	_	cf1*[86]	ana	16-4[90_86]	
16-2	1106-1110	says	_	_	_	_	_	_	_	
16-3	1111-1115	that	_	_	_	_	_	_	_	
16-4	1116-1119	his	object[89]|person[90]	giv:inact[89]|giv:act[90]	sssss[89]|ssssn[90]	_	cf2[89]|cf1*[90]	coref|ana	38-8[208_89]|16-10[91_90]	
16-5	1120-1127	gluteal	object[89]	giv:inact[89]	sssss[89]	_	cf2[89]	_	_	
16-6	1128-1135	abscess	object[89]	giv:inact[89]	sssss[89]	_	cf2[89]	_	_	
16-7	1136-1138	is	_	_	_	_	_	_	_	
16-8	1139-1148	improving	_	_	_	_	_	_	_	
16-9	1149-1152	and	_	_	_	_	_	_	_	
16-10	1153-1155	he	person[91]	giv:act[91]	ssssn[91]	_	cf1*[91]	ana	28-1[142_91]	
16-11	1156-1160	will	_	_	_	_	_	_	_	
16-12	1161-1163	be	_	_	_	_	_	_	_	
16-13	1164-1173	following	_	_	_	_	_	_	_	
16-14	1174-1176	up	_	_	_	_	_	_	_	
16-15	1177-1181	with	_	_	_	_	_	_	_	
16-16	1182-1189	Surgery	event[92]	new[92]	nnnnn[92]	_	cf4[92]	_	_	
16-17	1190-1195	today	time[93]	acc:com[93]	nnnnn[93]	_	cf3[93]	_	_	
16-18	1196-1197	.	_	_	_	_	_	_	_	

#Text=CURRENT MEDICATIONS :
17-1	1198-1205	CURRENT	abstract[98]	new[98]	snsnn[98]	_	cf1[98]	coref	47-5[230_98]	
17-2	1206-1217	MEDICATIONS	abstract[98]	new[98]	snsnn[98]	_	cf1[98]	_	_	
17-3	1218-1219	:	_	_	_	_	_	_	_	

#Text=1. Gabapentin 600 mg at night .
18-1	1220-1222	1.	_	_	_	_	_	_	_	
18-2	1223-1233	Gabapentin	substance[99]	new[99]	snnnn[99]	Gabapentin[99]	cf1[99]	_	_	
18-3	1234-1237	600	substance[101]	new[101]	nnnnn[101]	_	cf2[101]	_	_	
18-4	1238-1240	mg	substance[101]	new[101]	nnnnn[101]	_	cf2[101]	_	_	
18-5	1241-1243	at	_	_	_	_	_	_	_	
18-6	1244-1249	night	time[102]	new[102]	nnnnn[102]	_	cf3[102]	coref	24-5[126_102]	
18-7	1250-1251	.	_	_	_	_	_	_	_	

#Text=2. Metformin 1000 mg twice a day .
19-1	1252-1254	2.	_	_	_	_	_	_	_	
19-2	1255-1264	Metformin	substance[103]	new[103]	snnnn[103]	Metformin[103]	cf1[103]	_	_	
19-3	1265-1269	1000	substance[106]	new[106]	nnnnn[106]	_	cf2[106]	_	_	
19-4	1270-1272	mg	substance[106]	new[106]	nnnnn[106]	_	cf2[106]	_	_	
19-5	1273-1278	twice	_	_	_	_	_	_	_	
19-6	1279-1280	a	time[107]	new[107]	nnnnn[107]	_	cf3[107]	coref	20-5[111_107]	
19-7	1281-1284	day	time[107]	new[107]	nnnnn[107]	_	cf3[107]	_	_	
19-8	1285-1286	.	_	_	_	_	_	_	_	

#Text=3. Glipizide 5 mg a day .
20-1	1287-1289	3.	_	_	_	_	_	_	_	
20-2	1290-1299	Glipizide	substance[108]	new[108]	snnnn[108]	Glipizide[108]	cf2[108]	_	_	
20-3	1300-1301	5	substance[110]	new[110]	nnnnn[110]	_	cf3[110]	_	_	
20-4	1302-1304	mg	substance[110]	new[110]	nnnnn[110]	_	cf3[110]	_	_	
20-5	1305-1306	a	time[111]	giv:act[111]	nnnnn[111]	_	cf1*[111]	coref	21-7[115_111]	
20-6	1307-1310	day	time[111]	giv:act[111]	nnnnn[111]	_	cf1*[111]	_	_	
20-7	1311-1312	.	_	_	_	_	_	_	_	

#Text=4. Flagyl 500 mg four times a day .
21-1	1313-1315	4.	_	_	_	_	_	_	_	
21-2	1316-1322	Flagyl	substance[112]	giv:inact[112]	nnsnn[112]	Metronidazole[112]	cf2[112]	coref	41-8[217_112]	
21-3	1323-1326	500	substance[114]	new[114]	nnnnn[114]	_	cf3[114]	_	_	
21-4	1327-1329	mg	substance[114]	new[114]	nnnnn[114]	_	cf3[114]	_	_	
21-5	1330-1334	four	_	_	_	_	_	_	_	
21-6	1335-1340	times	_	_	_	_	_	_	_	
21-7	1341-1342	a	time[115]	giv:act[115]	nnnnn[115]	_	cf1*[115]	coref	22-6[119_115]	
21-8	1343-1346	day	time[115]	giv:act[115]	nnnnn[115]	_	cf1*[115]	_	_	
21-9	1347-1348	.	_	_	_	_	_	_	_	

#Text=5. Flexeril 10 mg twice a day .
22-1	1349-1351	5.	_	_	_	_	_	_	_	
22-2	1352-1360	Flexeril	substance[116]	new[116]	nnnnn[116]	Cyclobenzaprine[116]	cf2[116]	_	_	
22-3	1361-1363	10	substance[118]	new[118]	nnnnn[118]	_	cf3[118]	_	_	
22-4	1364-1366	mg	substance[118]	new[118]	nnnnn[118]	_	cf3[118]	_	_	
22-5	1367-1372	twice	_	_	_	_	_	_	_	
22-6	1373-1374	a	time[119]	giv:act[119]	nnnnn[119]	_	cf1*[119]	coref	23-5[123_119]	
22-7	1375-1378	day	time[119]	giv:act[119]	nnnnn[119]	_	cf1*[119]	_	_	
22-8	1379-1380	.	_	_	_	_	_	_	_	

#Text=6. Paroxetine 20 mg a day .
23-1	1381-1383	6.	_	_	_	_	_	_	_	
23-2	1384-1394	Paroxetine	substance[120]	new[120]	nnnnn[120]	Paroxetine[120]	cf2[120]	_	_	
23-3	1395-1397	20	substance[122]	new[122]	nnnnn[122]	_	cf3[122]	_	_	
23-4	1398-1400	mg	substance[122]	new[122]	nnnnn[122]	_	cf3[122]	_	_	
23-5	1401-1402	a	time[123]	giv:act[123]	nnnnn[123]	_	cf1*[123]	coref	25-6[133_123]	
23-6	1403-1406	day	time[123]	giv:act[123]	nnnnn[123]	_	cf1*[123]	_	_	
23-7	1407-1408	.	_	_	_	_	_	_	_	

#Text=7. Atripla one at night .
24-1	1409-1411	7.	_	_	_	_	_	_	_	
24-2	1412-1419	Atripla	substance[124]	giv:inact[124]	snssn[124]	Efavirenz/emtricitabine/tenofovir[124]	cf1[124]	coref	40-10[214_124]	
24-3	1420-1423	one	object[125]	new[125]	nnnnn[125]	_	cf3[125]	_	_	
24-4	1424-1426	at	_	_	_	_	_	_	_	
24-5	1427-1432	night	time[126]	giv:inact[126]	nnnnn[126]	_	cf2[126]	_	_	
24-6	1433-1434	.	_	_	_	_	_	_	_	

#Text=8. Clonazepam 1 mg twice a day .
25-1	1435-1437	8.	_	_	_	_	_	_	_	
25-2	1438-1448	Clonazepam	substance[127]	new[127]	nnnnn[127]	Clonazepam[127]	cf2[127]	_	_	
25-3	1449-1450	1	substance[132]	new[132]	nnnnn[132]	_	cf3[132]	_	_	
25-4	1451-1453	mg	substance[132]	new[132]	nnnnn[132]	_	cf3[132]	_	_	
25-5	1454-1459	twice	_	_	_	_	_	_	_	
25-6	1460-1461	a	time[133]	giv:inact[133]	nnnnn[133]	_	cf1[133]	_	_	
25-7	1462-1465	day	time[133]	giv:inact[133]	nnnnn[133]	_	cf1[133]	_	_	
25-8	1466-1467	.	_	_	_	_	_	_	_	

#Text=9. Blood pressure medicine , name unknown .
26-1	1468-1470	9.	_	_	_	_	_	_	_	
26-2	1471-1476	Blood	abstract[134]|abstract[135]|substance[136]	new[134]|new[135]|new[136]	nnnnn[134]|nsnnn[135]|nnnnn[136]	_	cf2[134]|cf3[135]|cf4[136]	bridge:other|coref|coref	26-6[137_134]|30-7[154_135]|30-7[155_136]	
26-3	1477-1485	pressure	abstract[134]|abstract[135]	new[134]|new[135]	nnnnn[134]|nsnnn[135]	_	cf2[134]|cf3[135]	_	_	
26-4	1486-1494	medicine	abstract[134]	new[134]	nnnnn[134]	_	cf2[134]	_	_	
26-5	1495-1496	,	_	_	_	_	_	_	_	
26-6	1497-1501	name	abstract[137]	acc:inf[137]	nnnnn[137]	_	cf1[137]	_	_	
26-7	1502-1509	unknown	_	_	_	_	_	_	_	
26-8	1510-1511	.	_	_	_	_	_	_	_	

#Text=REVIEW OF SYSTEMS :
27-1	1512-1518	REVIEW	abstract[140]	new[140]	nnnnn[140]	_	cf1[140]	_	_	
27-2	1519-1521	OF	abstract[140]	new[140]	nnnnn[140]	_	cf1[140]	_	_	
27-3	1522-1529	SYSTEMS	abstract[140]|abstract[141]	new[140]|new[141]	nnnnn[140]|nnnnn[141]	_	cf1[140]|cf2[141]	coref	28-8[146_141]	
27-4	1530-1531	:	_	_	_	_	_	_	_	

#Text=He otherwise has a negative review of systems .
28-1	1532-1534	He	person[142]	giv:inact[142]	ssssn[142]	_	cf2[142]	ana	32-1[174_142]	
28-2	1535-1544	otherwise	_	_	_	_	_	_	_	
28-3	1545-1548	has	_	_	_	_	_	_	_	
28-4	1549-1550	a	abstract[145]	new[145]	nnnnn[145]	_	cf3[145]	_	_	
28-5	1551-1559	negative	abstract[145]	new[145]	nnnnn[145]	_	cf3[145]	_	_	
28-6	1560-1566	review	abstract[145]	new[145]	nnnnn[145]	_	cf3[145]	_	_	
28-7	1567-1569	of	abstract[145]	new[145]	nnnnn[145]	_	cf3[145]	_	_	
28-8	1570-1577	systems	abstract[145]|abstract[146]	new[145]|giv:act[146]	nnnnn[145]|nnnnn[146]	_	cf3[145]|cf1*[146]	_	_	
28-9	1578-1579	.	_	_	_	_	_	_	_	

#Text=PHYSICAL EXAMINATION :
29-1	1580-1588	PHYSICAL	abstract[148]	new[148]	nnsnn[148]	_	cf1[148]	_	_	
29-2	1589-1600	EXAMINATION	abstract[148]	new[148]	nnsnn[148]	_	cf1[148]	_	_	
29-3	1601-1602	:	_	_	_	_	_	_	_	

#Text=VITAL SIGNS : Temperature 36.6 , blood pressure 145 / 90 , pulse 123 , respirations 20 , and weight is 89.9 kg ( 198 pounds . )
30-1	1603-1608	VITAL	abstract[149]	new[149]	nnnnn[149]	_	cf7[149]	_	_	
30-2	1609-1614	SIGNS	abstract[149]	new[149]	nnnnn[149]	_	cf7[149]	_	_	
30-3	1615-1616	:	_	_	_	_	_	_	_	
30-4	1617-1628	Temperature	abstract[150]	new[150]	nnnnn[150]	_	cf2[150]	coref	30-5[151_150]	
30-5	1629-1633	36.6	abstract[151]	giv:act[151]	nnnnn[151]	_	cf2[151]	_	_	
30-6	1634-1635	,	_	_	_	_	_	_	_	
30-7	1636-1641	blood	abstract[154]|substance[155]	giv:inact[154]|giv:inact[155]	nsnnn[154]|nnnnn[155]	_	cf3[154]|cf6[155]	coref	30-9[157_154]	
30-8	1642-1650	pressure	abstract[154]	giv:inact[154]	nsnnn[154]	_	cf3[154]	_	_	
30-9	1651-1654	145	abstract[157]	giv:act[157]	nsnnn[157]	_	cf3[157]	_	_	
30-10	1655-1656	/	abstract[157]	giv:act[157]	nsnnn[157]	_	cf3[157]	_	_	
30-11	1657-1659	90	abstract[157]	giv:act[157]	nsnnn[157]	_	cf3[157]	_	_	
30-12	1660-1661	,	_	_	_	_	_	_	_	
30-13	1662-1667	pulse	abstract[158]	new[158]	nsnnn[158]	_	cf4[158]	coref	30-14[159_158]	
30-14	1668-1671	123	abstract[159]	giv:act[159]	nsnnn[159]	_	cf4[159]	_	_	
30-15	1672-1673	,	_	_	_	_	_	_	_	
30-16	1674-1686	respirations	abstract[160]	new[160]	nnnnn[160]	_	cf5[160]	coref	30-17[161_160]	
30-17	1687-1689	20	abstract[161]	giv:act[161]	nnnnn[161]	_	cf5[161]	_	_	
30-18	1690-1691	,	_	_	_	_	_	_	_	
30-19	1692-1695	and	_	_	_	_	_	_	_	
30-20	1696-1702	weight	abstract[162]	new[162]	nnnnn[162]	_	cf1[162]	pred	30-22[168_162]	
30-21	1703-1705	is	_	_	_	_	_	_	_	
30-22	1706-1710	89.9	abstract[168]	giv:act[168]	nnnnn[168]	_	cf1[168]	appos	30-25[169_168]	
30-23	1711-1713	kg	abstract[168]	giv:act[168]	nnnnn[168]	_	cf1[168]	_	_	
30-24	1714-1715	(	_	_	_	_	_	_	_	
30-25	1716-1719	198	abstract[169]	giv:act[169]	nnnnn[169]	_	cf1[169]	_	_	
30-26	1720-1726	pounds	abstract[169]	giv:act[169]	nnnnn[169]	_	cf1[169]	_	_	
30-27	1727-1728	.	_	_	_	_	_	_	_	
30-28	1729-1730	)	_	_	_	_	_	_	_	

#Text=HEENT : Unremarkable except for some submandibular lymph nodes .
31-1	1731-1736	HEENT	abstract[170]	new[170]	nnnnn[170]	_	cf1[170]	_	_	
31-2	1737-1738	:	_	_	_	_	_	_	_	
31-3	1739-1751	Unremarkable	_	_	_	_	_	_	_	
31-4	1752-1758	except	_	_	_	_	_	_	_	
31-5	1759-1762	for	_	_	_	_	_	_	_	
31-6	1763-1767	some	object[172]	new[172]	nnnnn[172]	_	cf2[172]	_	_	
31-7	1768-1781	submandibular	object[172]	new[172]	nnnnn[172]	_	cf2[172]	_	_	
31-8	1782-1787	lymph	object[172]	new[172]	nnnnn[172]	_	cf2[172]	_	_	
31-9	1788-1793	nodes	object[172]	new[172]	nnnnn[172]	_	cf2[172]	_	_	
31-10	1794-1795	.	_	_	_	_	_	_	_	

#Text=His fundi are benign .
32-1	1796-1799	His	object[173]|person[174]	new[173]|giv:inact[174]	nnnnn[173]|ssssn[174]	_	cf2[173]|cf1[174]	coref	47-1[229_174]	
32-2	1800-1805	fundi	object[173]	new[173]	nnnnn[173]	_	cf2[173]	_	_	
32-3	1806-1809	are	_	_	_	_	_	_	_	
32-4	1810-1816	benign	_	_	_	_	_	_	_	
32-5	1817-1818	.	_	_	_	_	_	_	_	

#Text=NECK : Supple .
33-1	1819-1823	NECK	object[175]	new[175]	nnnnn[175]	_	cf1[175]	_	_	
33-2	1824-1825	:	_	_	_	_	_	_	_	
33-3	1826-1832	Supple	_	_	_	_	_	_	_	
33-4	1833-1834	.	_	_	_	_	_	_	_	

#Text=LUNGS : Clear to auscultation and percussion .
34-1	1835-1840	LUNGS	object[176]	new[176]	nnnnn[176]	_	cf1[176]	_	_	
34-2	1841-1842	:	_	_	_	_	_	_	_	
34-3	1843-1848	Clear	_	_	_	_	_	_	_	
34-4	1849-1851	to	_	_	_	_	_	_	_	
34-5	1852-1864	auscultation	abstract[177]	new[177]	nnnnn[177]	_	cf2[177]	_	_	
34-6	1865-1868	and	_	_	_	_	_	_	_	
34-7	1869-1879	percussion	abstract[178]	new[178]	nnnnn[178]	_	cf3[178]	_	_	
34-8	1880-1881	.	_	_	_	_	_	_	_	

#Text=CARDIAC : Reveals regular rate and rhythm without murmur , rub or gallop .
35-1	1882-1889	CARDIAC	_	_	_	_	_	_	_	
35-2	1890-1891	:	_	_	_	_	_	_	_	
35-3	1892-1899	Reveals	_	_	_	_	_	_	_	
35-4	1900-1907	regular	abstract[184]	new[184]	nnnnn[184]	_	cf1[184]	_	_	
35-5	1908-1912	rate	abstract[184]	new[184]	nnnnn[184]	_	cf1[184]	_	_	
35-6	1913-1916	and	abstract[184]	new[184]	nnnnn[184]	_	cf1[184]	_	_	
35-7	1917-1923	rhythm	abstract[184]|abstract[185]	new[184]|new[185]	nnnnn[184]|nnnnn[185]	_	cf1[184]|cf2[185]	_	_	
35-8	1924-1931	without	abstract[184]|abstract[185]	new[184]|new[185]	nnnnn[184]|nnnnn[185]	_	cf1[184]|cf2[185]	_	_	
35-9	1932-1938	murmur	abstract[184]|abstract[185]|event[186]	new[184]|new[185]|new[186]	nnnnn[184]|nnnnn[185]|nnnnn[186]	_	cf1[184]|cf2[185]|cf3[186]	_	_	
35-10	1939-1940	,	abstract[184]|abstract[185]	new[184]|new[185]	nnnnn[184]|nnnnn[185]	_	cf1[184]|cf2[185]	_	_	
35-11	1941-1944	rub	abstract[184]|abstract[185]|event[187]	new[184]|new[185]|new[187]	nnnnn[184]|nnnnn[185]|nnnnn[187]	_	cf1[184]|cf2[185]|cf4[187]	_	_	
35-12	1945-1947	or	abstract[184]|abstract[185]	new[184]|new[185]	nnnnn[184]|nnnnn[185]	_	cf1[184]|cf2[185]	_	_	
35-13	1948-1954	gallop	abstract[184]|abstract[185]|event[188]	new[184]|new[185]|new[188]	nnnnn[184]|nnnnn[185]|nnnnn[188]	_	cf1[184]|cf2[185]|cf5[188]	_	_	
35-14	1955-1956	.	_	_	_	_	_	_	_	

#Text=ABDOMEN : Soft and nontender without organomegaly or mass .
36-1	1957-1964	ABDOMEN	object[189]	new[189]	nnnnn[189]	_	cf1[189]	_	_	
36-2	1965-1966	:	_	_	_	_	_	_	_	
36-3	1967-1971	Soft	_	_	_	_	_	_	_	
36-4	1972-1975	and	_	_	_	_	_	_	_	
36-5	1976-1985	nontender	_	_	_	_	_	_	_	
36-6	1986-1993	without	_	_	_	_	_	_	_	
36-7	1994-2006	organomegaly	event[190]	new[190]	nnnnn[190]	_	cf2[190]	_	_	
36-8	2007-2009	or	_	_	_	_	_	_	_	
36-9	2010-2014	mass	object[191]	new[191]	nnnnn[191]	_	cf3[191]	_	_	
36-10	2015-2016	.	_	_	_	_	_	_	_	

#Text=EXTREMITIES : Show no cyanosis , clubbing or edema .
37-1	2017-2028	EXTREMITIES	object[192]	new[192]	nnnnn[192]	_	cf1[192]	_	_	
37-2	2029-2030	:	_	_	_	_	_	_	_	
37-3	2031-2035	Show	_	_	_	_	_	_	_	
37-4	2036-2038	no	_	_	_	_	_	_	_	
37-5	2039-2047	cyanosis	event[193]	new[193]	nnnnn[193]	_	cf2[193]	_	_	
37-6	2048-2049	,	_	_	_	_	_	_	_	
37-7	2050-2058	clubbing	event[194]	new[194]	nnnnn[194]	_	cf3[194]	_	_	
37-8	2059-2061	or	_	_	_	_	_	_	_	
37-9	2062-2067	edema	event[195]	new[195]	nnnnn[195]	_	cf4[195]	_	_	
37-10	2068-2069	.	_	_	_	_	_	_	_	

#Text=GU : Examination of the perineum revealed an open left gluteal wound that appears clear with no secretions .
38-1	2070-2072	GU	_	_	_	_	_	_	_	
38-2	2073-2074	:	_	_	_	_	_	_	_	
38-3	2075-2086	Examination	event[206]	new[206]	nnnnn[206]	_	cf2[206]	_	_	
38-4	2087-2089	of	event[206]	new[206]	nnnnn[206]	_	cf2[206]	_	_	
38-5	2090-2093	the	event[206]|object[207]	new[206]|new[207]	nnnnn[206]|nnnnn[207]	_	cf2[206]|cf3[207]	_	_	
38-6	2094-2102	perineum	event[206]|object[207]	new[206]|new[207]	nnnnn[206]|nnnnn[207]	_	cf2[206]|cf3[207]	_	_	
38-7	2103-2111	revealed	_	_	_	_	_	_	_	
38-8	2112-2114	an	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	coref	41-3[216_208]	
38-9	2115-2119	open	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-10	2120-2124	left	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-11	2125-2132	gluteal	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-12	2133-2138	wound	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-13	2139-2143	that	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-14	2144-2151	appears	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-15	2152-2157	clear	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-16	2158-2162	with	object[208]	giv:inact[208]	sssss[208]	_	cf1[208]	_	_	
38-17	2163-2165	no	object[208]|object[209]	giv:inact[208]|new[209]	sssss[208]|nnnnn[209]	_	cf1[208]|cf4[209]	_	_	
38-18	2166-2176	secretions	object[208]|object[209]	giv:inact[208]|new[209]	sssss[208]|nnnnn[209]	_	cf1[208]|cf4[209]	_	_	
38-19	2177-2178	.	_	_	_	_	_	_	_	

#Text=IMPRESSION :
39-1	2179-2189	IMPRESSION	abstract[210]	new[210]	nnnnn[210]	_	cf1[210]	_	_	
39-2	2190-2191	:	_	_	_	_	_	_	_	

#Text=1. Human immunodeficiency virus disease with stable control on Atripla .
40-1	2192-2194	1.	_	_	_	_	_	_	_	
40-2	2195-2200	Human	abstract[212]|animal[213]	giv:inact[212]|giv:inact[213]	sssss[212]|nssss[213]	HIV[213]	cf2[212]|cf3[213]	_	_	
40-3	2201-2217	immunodeficiency	abstract[212]|animal[213]	giv:inact[212]|giv:inact[213]	sssss[212]|nssss[213]	HIV[213]	cf2[212]|cf3[213]	_	_	
40-4	2218-2223	virus	abstract[212]|animal[213]	giv:inact[212]|giv:inact[213]	sssss[212]|nssss[213]	HIV[213]	cf2[212]|cf3[213]	_	_	
40-5	2224-2231	disease	abstract[212]	giv:inact[212]	sssss[212]	_	cf2[212]	_	_	
40-6	2232-2236	with	abstract[212]	giv:inact[212]	sssss[212]	_	cf2[212]	_	_	
40-7	2237-2243	stable	abstract[212]	giv:inact[212]	sssss[212]	_	cf2[212]	_	_	
40-8	2244-2251	control	abstract[212]	giv:inact[212]	sssss[212]	_	cf2[212]	_	_	
40-9	2252-2254	on	abstract[212]	giv:inact[212]	sssss[212]	_	cf2[212]	_	_	
40-10	2255-2262	Atripla	abstract[212]|substance[214]	giv:inact[212]|giv:inact[214]	sssss[212]|snssn[214]	Efavirenz/emtricitabine/tenofovir[214]	cf2[212]|cf1[214]	_	_	
40-11	2263-2264	.	_	_	_	_	_	_	_	

#Text=2. Resolving left gluteal abscess , completing Flagyl .
41-1	2265-2267	2.	_	_	_	_	_	_	_	
41-2	2268-2277	Resolving	_	_	_	_	_	_	_	
41-3	2278-2282	left	object[216]	giv:inact[216]	sssss[216]	_	cf2[216]	_	_	
41-4	2283-2290	gluteal	object[216]	giv:inact[216]	sssss[216]	_	cf2[216]	_	_	
41-5	2291-2298	abscess	object[216]	giv:inact[216]	sssss[216]	_	cf2[216]	_	_	
41-6	2299-2300	,	_	_	_	_	_	_	_	
41-7	2301-2311	completing	_	_	_	_	_	_	_	
41-8	2312-2318	Flagyl	substance[217]	giv:inact[217]	nnsnn[217]	Metronidazole[217]	cf1[217]	_	_	
41-9	2319-2320	.	_	_	_	_	_	_	_	

#Text=3. Diabetes mellitus , currently on oral therapy .
42-1	2321-2323	3.	_	_	_	_	_	_	_	
42-2	2324-2332	Diabetes	abstract[219]	giv:inact[219]	sssss[219]	Diabetes[219]	cf1[219]	_	_	
42-3	2333-2341	mellitus	abstract[219]	giv:inact[219]	sssss[219]	Diabetes[219]	cf1[219]	_	_	
42-4	2342-2343	,	_	_	_	_	_	_	_	
42-5	2344-2353	currently	_	_	_	_	_	_	_	
42-6	2354-2356	on	_	_	_	_	_	_	_	
42-7	2357-2361	oral	abstract[220]	giv:inact[220]	sssns[220]	_	cf2[220]	_	_	
42-8	2362-2369	therapy	abstract[220]	giv:inact[220]	sssns[220]	_	cf2[220]	_	_	
42-9	2370-2371	.	_	_	_	_	_	_	_	

#Text=4. Hypertension .
43-1	2372-2374	4.	_	_	_	_	_	_	_	
43-2	2375-2387	Hypertension	abstract[221]	giv:inact[221]	sssss[221]	_	cf1[221]	_	_	
43-3	2388-2389	.	_	_	_	_	_	_	_	

#Text=5. Depression .
44-1	2390-2392	5.	_	_	_	_	_	_	_	
44-2	2393-2403	Depression	abstract[222]	giv:inact[222]	sssss[222]	_	cf1[222]	_	_	
44-3	2404-2405	.	_	_	_	_	_	_	_	

#Text=6. Chronic musculoskeletal pain of unclear etiology .
45-1	2406-2408	6.	_	_	_	_	_	_	_	
45-2	2409-2416	Chronic	abstract[225]	giv:inact[225]	snssn[225]	_	cf1[225]	_	_	
45-3	2417-2432	musculoskeletal	abstract[225]	giv:inact[225]	snssn[225]	_	cf1[225]	_	_	
45-4	2433-2437	pain	abstract[225]	giv:inact[225]	snssn[225]	_	cf1[225]	_	_	
45-5	2438-2440	of	abstract[225]	giv:inact[225]	snssn[225]	_	cf1[225]	_	_	
45-6	2441-2448	unclear	abstract[225]|abstract[226]	giv:inact[225]|giv:inact[226]	snssn[225]|nnnnn[226]	_	cf1[225]|cf2[226]	_	_	
45-7	2449-2457	etiology	abstract[225]|abstract[226]	giv:inact[225]|giv:inact[226]	snssn[225]|nnnnn[226]	_	cf1[225]|cf2[226]	_	_	
45-8	2458-2459	.	_	_	_	_	_	_	_	

#Text=PLAN :
46-1	2460-2464	PLAN	abstract[227]	new[227]	snnnn[227]	_	cf1[227]	_	_	
46-2	2465-2466	:	_	_	_	_	_	_	_	

#Text=The patient will continue his current medications .
47-1	2467-2470	The	person[229]	giv:inact[229]	ssssn[229]	_	cf1[229]	ana	47-5[231_229]	
47-2	2471-2478	patient	person[229]	giv:inact[229]	ssssn[229]	_	cf1[229]	_	_	
47-3	2479-2483	will	_	_	_	_	_	_	_	
47-4	2484-2492	continue	_	_	_	_	_	_	_	
47-5	2493-2496	his	abstract[230]|person[231]	giv:inact[230]|giv:act[231]	snsnn[230]|ssssn[231]	_	cf2[230]|cf1[231]	ana	48-1[232_231]	
47-6	2497-2504	current	abstract[230]	giv:inact[230]	snsnn[230]	_	cf2[230]	_	_	
47-7	2505-2516	medications	abstract[230]	giv:inact[230]	snsnn[230]	_	cf2[230]	_	_	
47-8	2517-2518	.	_	_	_	_	_	_	_	

#Text=He will have laboratory studies done in 3 to 4 weeks , and we will see him a few weeks thereafter .
48-1	2519-2521	He	person[232]	giv:act[232]	ssssn[232]	_	cf1*[232]	ana	48-17[238_232]	
48-2	2522-2526	will	_	_	_	_	_	_	_	
48-3	2527-2531	have	_	_	_	_	_	_	_	
48-4	2532-2542	laboratory	abstract[235]	new[235]	snsns[235]	_	cf4[235]	_	_	
48-5	2543-2550	studies	abstract[235]	new[235]	snsns[235]	_	cf4[235]	_	_	
48-6	2551-2555	done	_	_	_	_	_	_	_	
48-7	2556-2558	in	_	_	_	_	_	_	_	
48-8	2559-2560	3	time[236]	new[236]	snsns[236]	_	cf3[236]	coref	48-18[241_236]	
48-9	2561-2563	to	time[236]	new[236]	snsns[236]	_	cf3[236]	_	_	
48-10	2564-2565	4	time[236]	new[236]	snsns[236]	_	cf3[236]	_	_	
48-11	2566-2571	weeks	time[236]	new[236]	snsns[236]	_	cf3[236]	_	_	
48-12	2572-2573	,	_	_	_	_	_	_	_	
48-13	2574-2577	and	_	_	_	_	_	_	_	
48-14	2578-2580	we	person[237]	acc:com[237]	nnnnn[237]	_	cf2[237]	_	_	
48-15	2581-2585	will	_	_	_	_	_	_	_	
48-16	2586-2589	see	_	_	_	_	_	_	_	
48-17	2590-2593	him	person[238]	giv:act[238]	ssssn[238]	_	cf1*[238]	ana	49-1[242_238]	
48-18	2594-2595	a	time[241]	acc:com[241]	snsns[241]	_	cf3[241]	_	_	
48-19	2596-2599	few	time[241]	acc:com[241]	snsns[241]	_	cf3[241]	_	_	
48-20	2600-2605	weeks	time[241]	acc:com[241]	snsns[241]	_	cf3[241]	_	_	
48-21	2606-2616	thereafter	time[241]	acc:com[241]	snsns[241]	_	cf3[241]	_	_	
48-22	2617-2618	.	_	_	_	_	_	_	_	

#Text=He has been encouraged to keep his appointment with his psychologist .
49-1	2619-2621	He	person[242]	giv:act[242]	ssssn[242]	_	cf1*[242]	ana	49-7[245_242]	
49-2	2622-2625	has	_	_	_	_	_	_	_	
49-3	2626-2630	been	_	_	_	_	_	_	_	
49-4	2631-2641	encouraged	_	_	_	_	_	_	_	
49-5	2642-2644	to	_	_	_	_	_	_	_	
49-6	2645-2649	keep	_	_	_	_	_	_	_	
49-7	2650-2653	his	event[244]|person[245]	new[244]|giv:act[245]	nnnnn[244]|ssssn[245]	_	cf2[244]|cf1*[245]	ana	49-10[248_245]	
49-8	2654-2665	appointment	event[244]	new[244]	nnnnn[244]	_	cf2[244]	_	_	
49-9	2666-2670	with	event[244]	new[244]	nnnnn[244]	_	cf2[244]	_	_	
49-10	2671-2674	his	event[244]|person[247]|person[248]	new[244]|new[247]|giv:act[248]	nnnnn[244]|nnsns[247]|ssssn[248]	_	cf2[244]|cf3[247]|cf1*[248]	_	_	
49-11	2675-2687	psychologist	event[244]|person[247]	new[244]|new[247]	nnnnn[244]|nnsns[247]	_	cf2[244]|cf3[247]	_	_	
49-12	2688-2689	.	_	_	_	_	_	_	_	
